ZHENGYE BIOTECHNOLOGY HOLDING LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • August 22nd, 2024 • Zhengye Biotechnology Holding LTD • Pharmaceutical preparations
The undersigned, Zhengye Biotechnology Holding Limited, an exempted company incorporated in the Cayman Islands (the “Company”), hereby confirms its agreement (this “Agreement”) with Kingswood Capital Partners, LLC, the representative of several underwriters as disclosed in Schedule A attached hereto (the “Representative,” and collectively with the several underwriters, the “Underwriters”) to issue and sell to the Underwriters an aggregate of 1,500,000 ordinary shares, par value US$0.000025 per share, of the Company (the “Firm Shares”). At the options of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell to the Underwriters up to an aggregate of 225,000 ordinary shares, par value US$0.000025 per share, of the Company (the “Option Shares,” and collectively with the Firm Shares, the “Securities”). The offering and sale of Securities contemplated by this Agreement is referred to herein as the “Offering.”
